S&P Global Inc. (SPGI)
NYSE: SPGI · Real-Time Price · USD
545.66
-5.44 (-0.99%)
At close: Aug 1, 2025, 4:00 PM
552.00
+6.34 (1.16%)
After-hours: Aug 1, 2025, 7:59 PM EDT

Sage Therapeutics Revenue

S&P Global had revenue of $3.76B in the quarter ending June 30, 2025, with 5.80% growth. This brings the company's revenue in the last twelve months to $14.70B, up 10.73% year-over-year. In the year 2024, S&P Global had annual revenue of $14.21B with 13.69% growth.

Revenue (ttm)
$14.70B
Revenue Growth
+10.73%
P/S Ratio
11.44
Revenue / Employee
$347,107
Employees
42,350
Market Cap
166.58B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202414.21B1.71B13.69%
Dec 31, 202312.50B1.32B11.77%
Dec 31, 202211.18B2.88B34.76%
Dec 31, 20218.30B855.00M11.49%
Dec 31, 20207.44B743.00M11.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition